Lenvatinib Mesylate and Methoxsalen Extracorporeal Solution
Determining the interaction of Lenvatinib Mesylate and Methoxsalen Extracorporeal Solution and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: methoxsalen
Brand name: 8-Mop, Oxsoralen-Ultra, Uvadex
Synonyms: Methoxsalen, Methoxsalen (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Methoxsalen Hard-Gelatin Capsules
- Lenvatinib Mesylate-Methoxsalen injection
- Lenvatinib Mesylate-Methoxsalen Soft-Gelatin Capsules
- Lenvatinib Mesylate-Methoxy Polyethylene Glycol-Epoetin Beta
- Lenvatinib Mesylate-Methoxy polyethylene glycol-epoetin beta Injection
- Lenvatinib Mesylate-Methoxyflurane
- Methoxsalen Extracorporeal Solution-Lenvima
- Methoxsalen Extracorporeal Solution-Lenvima (14 MG Daily Dose)
- Methoxsalen Extracorporeal Solution-Lenvima (18 MG Daily Dose)
- Methoxsalen Extracorporeal Solution-Lenvima (20 MG Daily Dose)
- Methoxsalen Extracorporeal Solution-Lenvima (24 MG Daily Dose)
- Methoxsalen Extracorporeal Solution-Lenvima (8 MG Daily Dose)